Navigation Links
Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
Date:6/19/2008

CINCINNATI, June 19 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading global full-service clinical research organization (CRO), today announced that several of its experts will present at the upcoming Drug Information Association (DIA) 44th Annual Meeting. The meeting is scheduled for June 22-26, 2008, at the Boston Convention and Exhibition Center in Boston, Mass. Kendle's experts will speak on key topics in the clinical development industry, including EDC, biomarkers, regulatory affairs, adaptive clinical trial design, professional development and patient access and retention.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

In addition to attending presentations by Kendle speakers, attendees at the DIA Annual Meeting may visit Kendle experts at two booths in the exhibit hall. Booth 1804 will focus on the company's global Phase I-IV service offerings and will preview its recently expanded Early Phase capabilities following the June 2 acquisition of DecisionLine Clinical Research Corporation, an early phase CRO specializing in the conduct of Phase I studies involving the measurement of pharmacodynamic effects of central nervous system (CNS) drugs. Booth 456 will focus on career opportunities at Kendle.

Kendle speakers include:

June 23

EDC: Faster Horse or Model T?

Sylva Collins, PhD, Vice President, Global Biometrics

10:30 a.m. - 12 p.m.

June 24

Biomarkers and Surrogate Endpoints: Definitions, Background, and

Validation

Lisa Jenkins, PhD, Regulatory Group Leader

8 - 9:30 a.m.

General Process and Best Practices for EOP2 and Pre-NDA Meetings

Lisa Jenkins, PhD, Regulatory Group Leader

10 - 11:30 a.m.

Recent Advances in Adaptive Clinical Trial Designs

Lisa Jenkins, PhD, Regulatory Group Leader

2 - 3:30 p.m.

June 25

Marketing Yourself as a Candidate in a Competitive Clinical Research Job

Market

Bill Neese, MBA, Director, Global Recruitment

10:30 a.m. - 12 p.m.

June 26

Global Patient Recruitment and Retention: Identifying and Overcoming

Barriers to Accelerate Patient Recruitment and Retention Worldwide

Janet Jones, PhD, Senior Director, Strategic Patient Access

8:30 - 10 a.m.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the company's Web site at http://www.kendle.com .
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. William L Wherle https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=26220


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Promise of Vicals CMV Vaccine Noted by Independent Experts
2. Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
3. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
4. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
5. Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children
6. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
7. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
8. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
9. Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008
10. Oridion Announces Major Medical Research and Congress Presentations
11. Nventa to Present at Bio 2008 International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016 Velano Vascular, a ... for hospitalized patients and their practitioners, announced today that ... funding. Velano will use the proceeds from this financing, ... completed in January 2015, to support the development and ... and pediatric populations. Philadelphia ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016  HemaFlo Therapeutics, Inc. ... (USPTO) has issued US Patent Number 9,119,880 covering the use ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ... --> Dale Peterson , PhD, HemaFlo,s founder, ... a powerful technology." --> Dale Peterson ...
(Date:2/8/2016)... NORTHBROOK, Ill. , Feb. 8, 2016  Astellas Pharma ... today announced the promotion of James Robinson as ... the company,s operations in North and South America ... president, Astellas Pharma US, representing the commercial organization in ... assumed in 2013. Masao Yoshida , who ...
Breaking Medicine Technology:
(Date:2/8/2016)... , ... February 08, 2016 , ... Guruji Mahendra Kumar ... 10th and 11th, 2016 in honor of his birthday on February 10th. During ... Mahendra Trivedi is known by over 250,000 people from over 40 different countries ...
(Date:2/7/2016)... Metamora, Michigan (PRWEB) , ... February 07, 2016 ... ... pelvic organ prolapse with the latest techniques and the most minimally invasive approaches. ... pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to the ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... ... ... With the FCPX LUT: Summer pack from Pixel Film Studios, ... is a Lookup Table that contains a mathematical formula for modifying an image. The ... manipulating each pixel, LUT's can change each color range differently, it gives the user ...
(Date:2/5/2016)... SARASOTA, Florida (PRWEB) , ... February 05, 2016 , ... ... an event he has completed every year since it started in 2003. This year, ... attracting the attention of fellow runners and NBA team the Miami Heat. , This ...
Breaking Medicine News(10 mins):